{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:02Z","timestamp":1787020682989,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2024ZZ1023"],"award-info":[{"award-number":["2024ZZ1023"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010108","name":"Zhongshan Hospital","doi-asserted-by":"publisher","award":["2023-2ZSCX02"],"award-info":[{"award-number":["2023-2ZSCX02"]}],"id":[{"id":"10.13039\/501100010108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01723-1","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:56:39Z","timestamp":1762253799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic value of AHNAK2 immunohistochemical expression in papillary thyroid carcinoma: an immunohistochemical study"],"prefix":"10.1186","volume":"20","author":[{"given":"Xinyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minying","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akesu","family":"Sujie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"1723_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fendo.2020.00082","volume":"11","author":"D Laha","year":"2020","unstructured":"Laha D, Nilubol N. Boufraqech. New therapies for advanced thyroid cancer. Front Endocrinol (Lausanne). 2020;11:82.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1723_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2559.2004.01876.x","volume":"45","author":"ML Prasad","year":"2004","unstructured":"Prasad ML, Huang Y, Pellegata NS, et al. Hashimoto\u2019s thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC. Histopathology. 2004;45(1):39\u201346.","journal-title":"Histopathology"},{"issue":"4","key":"1723_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.25122\/jml-2021-0415","volume":"15","author":"MHA Wahid","year":"2022","unstructured":"Wahid MHA, Almudhafar RH. Comparative BRAF V600E immunohistochemical expression in differentiated thyroid tumors with papillary features. J Med Life. 2022;15(4):520\u20135.","journal-title":"J Med Life"},{"issue":"1","key":"1723_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4149\/neo_2019_190128N86","volume":"67","author":"D Kalfert","year":"2020","unstructured":"Kalfert D, Ludvikova M, Kholova I, et al. Combined use of galectin-3 and thyroid peroxidase improves the differential diagnosis of thyroid tumors. Neoplasma. 2020;67(1):164\u201370.","journal-title":"Neoplasma"},{"issue":"3","key":"1723_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1385\/EP:13:3:207","volume":"13","author":"S Erkili\u00e7","year":"2002","unstructured":"Erkili\u00e7 S, Aydin A, Ko\u00e7er NE. Diagnostic utility of cytokeratin 19 expression in multinodular goiter with papillary areas and papillary carcinoma of thyroid. Endocr Pathol. 2002;13(3):207\u201311.","journal-title":"Endocr Pathol"},{"issue":"2","key":"1723_CR6","first-page":"113","volume":"96","author":"A Zehani","year":"2018","unstructured":"Zehani A, Bani A, Chelly I, et al. Papillary thyroid tumors: diagnostic value of CD56 and cytokeratin 19. Tunis Med. 2018;96(2):113\u201321.","journal-title":"Tunis Med"},{"issue":"6","key":"1723_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/(SICI)1097-0215(19980610)76:6<806::AID-IJC7>3.0.CO;2-1","volume":"76","author":"D Lazzereschi","year":"1998","unstructured":"Lazzereschi D, Sambuco L, Carnovale Scalzo C, et al. Cyclin D1 and cyclin E expression in malignant thyroid cells and in human thyroid carcinomas. Int J Cancer. 1998;76(6):806\u201311.","journal-title":"Int J Cancer"},{"key":"1723_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030528","author":"M Zardab","year":"2022","unstructured":"Zardab M, Stasinos K, Grose RP, et al. The obscure potential of AHNAK2. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14030528.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1723_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","volume":"33","author":"ZW Baloch","year":"2022","unstructured":"Baloch ZW, Asa SL, Barletta JA, et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022;33(1):27\u201363.","journal-title":"Endocr Pathol"},{"issue":"3","key":"1723_CR10","first-page":"815","volume":"147","author":"XC Xu","year":"1995","unstructured":"Xu XC, el-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol. 1995;147(3):815\u201322.","journal-title":"Am J Pathol"},{"issue":"9","key":"1723_CR11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1136\/jcp.2010.076901","volume":"63","author":"X Zhu","year":"2010","unstructured":"Zhu X, Sun T, Lu H, et al. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma. J Clin Pathol. 2010;63(9):786\u20139.","journal-title":"J Clin Pathol"},{"issue":"12","key":"1723_CR12","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.1073\/pnas.89.12.5472","volume":"89","author":"E Shtivelman","year":"1992","unstructured":"Shtivelman E, Cohen FE, Bishop JM. A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. Proc Natl Acad Sci U S A. 1992;89(12):5472\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1723_CR13","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.4149\/neo_2021_210304N276","volume":"68","author":"QY Lin","year":"2021","unstructured":"Lin QY, Qi QL, Hou S, et al. Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt\/\u03b2-catenin pathway. Neoplasma. 2021;68(5):1063\u201371.","journal-title":"Neoplasma"},{"key":"1723_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.120032","volume":"286","author":"R Ye","year":"2021","unstructured":"Ye R, Liu D, Guan H, et al. Ahnak2 promotes thyroid carcinoma progression by activating the NF-\u03baB pathway. Life Sci. 2021;286:120032.","journal-title":"Life Sci"},{"key":"1723_CR15","unstructured":"Xu M, Wen J, Xu Q et al. AHNAK2 promotes the progression of differentiated thyroid cancer through PI3K\/AKT signaling pathway. Curr Cancer Drug Targets. 2022."},{"issue":"2","key":"1723_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2011.09.003","volume":"313","author":"AU Newlaczyl","year":"2011","unstructured":"Newlaczyl AU, Yu LG. Galectin-3\u2013a jack-of-all-trades in cancer. Cancer Lett. 2011;313(2):123\u20138.","journal-title":"Cancer Lett"},{"issue":"14","key":"1723_CR17","first-page":"3015","volume":"58","author":"F Orlandi","year":"1998","unstructured":"Orlandi F, Saggiorato E, Pivano G, et al. Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res. 1998;58(14):3015\u201320.","journal-title":"Cancer Res"},{"issue":"1","key":"1723_CR18","first-page":"36","volume":"20","author":"HA Aiad","year":"2008","unstructured":"Aiad HA, Kandil MA, Asaad NY, et al. Galectin-3 immunostaining in cytological and histopathological diagnosis of thyroid lesions. J Egypt Natl Canc Inst. 2008;20(1):36\u201346.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"1","key":"1723_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/CCO.0b013e32834dcfca","volume":"24","author":"C Theoharis","year":"2012","unstructured":"Theoharis C, Roman S, Sosa JA. The molecular diagnosis and management of thyroid neoplasms. Curr Opin Oncol. 2012;24(1):35\u201341.","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"1723_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ccr.2004.09.022","volume":"6","author":"MJ Garnett","year":"2004","unstructured":"Garnett MJ, Marais R. Guilty as charged: B-RAF is a human oncogene. Cancer Cell. 2004;6(4):313\u20139.","journal-title":"Cancer Cell"},{"issue":"6","key":"1723_CR21","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1210\/jc.2006-1613","volume":"92","author":"D Liu","year":"2007","unstructured":"Liu D, Liu Z, Condouris S, et al. BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells. J Clin Endocrinol Metab. 2007;92(6):2264\u201371.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1723_CR22","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1210\/me.2003-0041","volume":"17","author":"J Wang","year":"2003","unstructured":"Wang J, Knauf JA, Basu S, et al. Conditional expression of RET\/PTC induces a weak oncogenic drive in thyroid PCCL3 cells and inhibits thyrotropin action at multiple levels. Mol Endocrinol. 2003;17(7):1425\u201336.","journal-title":"Mol Endocrinol"},{"issue":"8","key":"1723_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1089\/thy.2009.0074","volume":"19","author":"I Marchetti","year":"2009","unstructured":"Marchetti I, Lessi F, Mazzanti CM, et al. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Thyroid. 2009;19(8):837\u201342.","journal-title":"Thyroid"},{"issue":"3","key":"1723_CR24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1530\/EJE-09-0353","volume":"161","author":"MC Zatelli","year":"2009","unstructured":"Zatelli MC, Trasforini G, Leoni S, et al. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies. Eur J Endocrinol. 2009;161(3):467\u201373.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1723_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231341","volume":"15","author":"S Al-Salam","year":"2020","unstructured":"Al-Salam S, Sharma C, Afandi B, et al. BRAF and KRAS mutations in papillary thyroid carcinoma in the united Arab Emirates. PLoS ONE. 2020;15(4):e0231341.","journal-title":"PLoS ONE"},{"issue":"4","key":"1723_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/path.2183","volume":"212","author":"S Scarpino","year":"2007","unstructured":"Scarpino S, Di Napoli A, Melotti F, et al. Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF-D production by tumour cells. J Pathol. 2007;212(4):411\u20139.","journal-title":"J Pathol"},{"issue":"2","key":"1723_CR27","first-page":"111","volume":"40","author":"S Muthusamy","year":"2018","unstructured":"Muthusamy S, Azhar Sha S, Abdullah Suhaimi SN, et al. CD56 expression in benign and malignant thyroid lesions. Malays J Pathol. 2018;40(2):111\u20139.","journal-title":"Malays J Pathol"},{"key":"1723_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-6-126","volume":"6","author":"Q Song","year":"2011","unstructured":"Song Q, Wang D, Lou Y, et al. Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the Northeastern region of China. Diagn Pathol. 2011;6:126.","journal-title":"Diagn Pathol"},{"issue":"8","key":"1723_CR29","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nrc3090","volume":"11","author":"EA Musgrove","year":"2011","unstructured":"Musgrove EA, Caldon CE, Barraclough J, et al. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer. 2011;11(8):558\u201372.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1723_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1385\/ENDO:8:1:61","volume":"8","author":"M Zou","year":"1998","unstructured":"Zou M, Shi Y, Farid NR, et al. Inverse association between cyclin D1 overexpression and retinoblastoma gene mutation in thyroid carcinomas. Endocrine. 1998;8(1):61\u20134.","journal-title":"Endocrine"},{"issue":"12","key":"1723_CR31","first-page":"1210","volume":"51","author":"SR He","year":"2022","unstructured":"He SR, Zhang JX, Chen RM, et al. [Diagnostic values of Cyclin D1 immunocytochemistry and molecular testing in preoperative fine needle aspiration of undeterminate thyroid nodules]. Zhonghua Bing Li Xue Za Zhi. 2022;51(12):1210\u20136.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"5","key":"1723_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.prp.2008.11.011","volume":"205","author":"D El Demellawy","year":"2009","unstructured":"El Demellawy D, Nasr AL, Babay S, et al. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid. Pathol Res Pract. 2009;205(5):303\u20139.","journal-title":"Pathol Res Pract"},{"issue":"5","key":"1723_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/15321819.2018.1514508","volume":"39","author":"AG Abdou","year":"2018","unstructured":"Abdou AG, Abdelwahed M, Said A, et al. Evaluation of the diagnostic value of Emerin and CD56 in papillary thyroid carcinoma - an immunohistochemical study. J Immunoassay Immunochem. 2018;39(5):521\u201337.","journal-title":"J Immunoassay Immunochem"},{"issue":"5","key":"1723_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1600-0463.2011.02842.x","volume":"120","author":"I Paunovic","year":"2012","unstructured":"Paunovic I, Isic T, Havelka M, et al. Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors. APMIS. 2012;120(5):368\u201379.","journal-title":"APMIS"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01723-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01723-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01723-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:28:46Z","timestamp":1762295326000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01723-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1723"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01723-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript is an original work by all authors. All authors made a significant contribution to this study. All the authors have read and approved the final version of the manuscript. This study was performed in accordance with the research policies approved by Zhongshan Hospital, Fudan University (No: B2024-169).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}